Pulmotect
Clinical stage biotech company, developing products that boost the innate immune system to protect against a wide range of lung infections. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$24—35m (Dealroom.co estimates Sep 2024.)
Houston Texas (HQ)
Authorizing premium user...